Sportradar Group AG (SRAD) Most Active Options

The 25 most actively traded Sportradar Group AG (SRAD) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$15.58
52-week range
$12.36 – $31.78
ATM IV (30d)
49.8%
IV rank
33 / 100
Low
Expected move
±$1.07 (±6.9%)
Put/call OI
0.27
Call-heavy
Max pain
$12.5
↓ 19.7% below close

Most Active SRAD Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
SRAD $5 put Nov 20, 2026 133d $0.09 110.6% 19 -0.02 450 350 87.2× avg
SRAD $7.5 put Nov 20, 2026 133d $0.20 81.1% 9 -0.04 48 150 37.4× avg
SRAD $17.5 put Aug 21, 2026 42d $2.35 68.8% 41 -0.66 505 100 6.9× avg
SRAD $7.5 put Jan 15, 2027 189d $0.18 75.6% 7 -0.05 849 56 14.0× avg
SRAD $15 call Dec 18, 2026 161d $3.20 68.1% 56 0.63 12,673 52 2.3× avg
SRAD $20 call Aug 21, 2026 42d $0.40 75.5% 43 0.19 5,443 51 0.3× avg
SRAD $15 call Aug 21, 2026 42d $1.70 66.5% 80 0.60 4,091 47 0.3× avg
SRAD $15 put Aug 21, 2026 42d $1.05 65.0% 58 -0.40 1,309 26 3.0× avg
SRAD $10 put Jan 15, 2027 189d $0.47 71.7% 5 -0.13 463 24 6.0× avg
SRAD $25 call Jul 16, 2027 371d $1.90 62.6% 12 0.35 733 23 3.3× avg
SRAD $40 call Jan 21, 2028 560d $1.19 73.2% 29 0.30 52 18 2.6× avg
SRAD $17.5 call Aug 21, 2026 42d $0.75 71.1% 82 0.35 3,785 16 0.1× avg
SRAD $30 call Jan 21, 2028 560d $2.07 63.7% 14 0.35 446 16 2.3× avg
SRAD $27.5 call Nov 20, 2026 133d $0.35 66.9% 19 0.12 445 12 1.7× avg
SRAD $15 call Jul 17, 2026 7d $0.82 49.8% 0 0.68 1,273 11 1.0× avg
SRAD $17.5 call Nov 20, 2026 133d $1.95 64.9% 45 0.46 704 10 0.7× avg
SRAD $17.5 call Jul 17, 2026 7d $0.05 70.3% 0 0.11 1,431 10 1.0× avg
SRAD $15 call Nov 20, 2026 133d $2.75 58.5% 16 0.62 929 8 0.4× avg
SRAD $20 call Jul 17, 2026 7d $0.02 110.4% 7 0.05 4,593 7 0.1× avg
SRAD $20 call Nov 20, 2026 133d $1.14 66.6% 59 0.34 979 7 0.3× avg
SRAD $17.5 call Dec 18, 2026 161d $2.20 64.1% 41 0.48 11,717 4 0.3× avg
SRAD $22.5 call Aug 21, 2026 42d $0.27 80.6% 6 0.11 365 2 0.4× avg
SRAD $22.5 call Nov 20, 2026 133d $0.70 68.1% 21 0.25 2,016 1 0.1× avg
SRAD $15 call Feb 19, 2027 224d $3.60 65.6% 46 0.64 22 1 0.0× avg
SRAD $15 put Jul 17, 2026 7d $0.25 61.4% 0 -0.35 550 1 1.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active SRAD contract today is the $5 put expiring in 133 days, with 350 contracts traded. Calls dominate the most-active list (18 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on SRAD for free

Build multi-leg SRAD strategies, visualize payoffs, and scan the full US options universe with OptiView.

SRAD Options FAQ

Which SRAD option contract is most active today?

The most traded SRAD contract is the $5 put expiring Nov 20, 2026, with 350 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active SRAD options?

The table lists the 25 SRAD contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.